The Knight ADRC is dedicated to advancing the understanding and treatment of Alzheimer disease and related dementias in all people through our multidisciplinary approach. Our goal is to improve diagnosis and care, promote quality research (clinical trials and observational studies), engage in meaningful outreach, and provide helpful education.
We strive for a team of administrative, research and clinical faculty and staff that is reflective of St. Louis. The Knight ADRC acknowledges the need for multiple voices, and we are committed to listening to our research participants. We embrace the differences that exist within the St. Louis metropolitan area, and value the time, effort, and dedication of everyone involved in helping us diagnose, treat, and ultimately prevent Alzheimer disease.
DID YOU KNOW?
- African Americans are two to three times more likely to develop Alzheimer disease than non-Hispanic whites, while Latinos are 1.5 times more likely*
- Latinos and African Americans will make up nearly 40% of the 8.4 million Americans projected to be living with Alzheimer disease in 2030*
- Currently, Latinos make up just 5.4% of National Institutes of Health (NIH) funded Alzheimer disease research studies and African Americans make up 14% despite being 1.5 and 2-3 times more at risk for the disease, respectively*
* Source: UsAgainstAlzheimers.org